Cabot (NYSE:CBT - Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share guidance of 7.150-7.500 for the period, compared to the consensus earnings per share estimate of 7.520. The company issued revenue guidance of -.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on CBT. Mizuho decreased their price target on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a report on Tuesday, January 7th. JPMorgan Chase & Co. lowered their price target on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research report on Friday, February 21st. StockNews.com raised Cabot from a "hold" rating to a "buy" rating in a research report on Thursday, April 17th. Finally, UBS Group decreased their target price on Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a report on Monday, April 7th.
Check Out Our Latest Analysis on Cabot
Cabot Price Performance
NYSE:CBT traded down $0.51 during trading hours on Monday, reaching $77.48. 602,061 shares of the company were exchanged, compared to its average volume of 396,425. The stock's 50-day moving average is $81.15 and its 200-day moving average is $92.32. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72. The firm has a market cap of $4.20 billion, a PE ratio of 10.29, a price-to-earnings-growth ratio of 0.74 and a beta of 0.91. Cabot has a twelve month low of $72.29 and a twelve month high of $117.46.
Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.04. Cabot had a return on equity of 26.79% and a net margin of 10.60%. On average, sell-side analysts anticipate that Cabot will post 7.57 earnings per share for the current fiscal year.
About Cabot
(
Get Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.